Mardi Gomberg-Maitland, MD, MSc is a cardiologist and Professor of Medicine at the GW School of Medicine & Health Sciences. She also serves as the Medical Director of the MFA/GWUH Pulmonary Hypertension Program and has built a comprehensive management program to include outpatient and inpatient diagnosis and treatment, noninvasive and invasive testing, and state of the art pulmonary hypertension medication options.
Dr. Gomberg-Maitland earned her Bachelor’s degree from Yale, completed her medical degree at Albert Einstein College of Medicine of Yeshiva University, with a special distinction for research in cardiovascular medicine. She served her residency in internal medicine at New York Presbyterian Hospital, Weill-Cornell Medical Center and was accepted for fellowship in cardiovascular diseases at Mount Sinai Medical Center. Dr. Gomberg-Maitland was also a visiting fellow in critical care medicine at the New York Presbyterian Hospital/Weill-Cornell Medical Center. She earned a Master’s degree in clinical epidemiology from the Harvard School of Public Health. She is boarded in Internal Medicine and Cardiovascular Disease and is licensed in Washington, DC and the Commonwealth of Virginia.
Dr. Gomberg-Maitland is an expert clinician and researcher in the field of pulmonary heart disease. She has participated in dozens of multicenter, multinational research trials to explore new therapies for pulmonary hypertension. Her research focus is in understanding the epidemiology of pulmonary hypertension and development of novel therapeutics and biomarkers.
Dr. Gomberg-Maitland is internationally known for her work, has had extensive grant funding and is extensively published with over 150 articles, abstracts, reviews and chapters. She has published in peer-reviewed journals, including the Journal of the American College of Cardiology, JACC Heart Failure, Pulmonary Circulation, European Respiratory Journal, Chest, and the Journal of Heart and Lung Transplantation.
- Articles from 2019
Sitbon O, Gomberg-Maitland M, Granton J, Lewis MI, Mathai SC, Rainisio M, Stockbridge NL, Wilkins MR, Zamanian RT, Rubin LJ. Clinical trial design and new therapies for pulmonary arterial hypertension. Eur Resp J. 2019 Jan 24;53(1) pii:1801908. Dec. 13. (epub) PMID: 30545975
Benza RL, Gomberg-Maitland M, Elliott G, Farber HWA, Foreman AJ, Frost AE, McGoon MD, Pasta DJ, Selej M, Burger C, Frantz RP. An update of the risk score calculator in pulmonary arterial hypertension patients from the registry to evaluate early and long-term PAH disease management (REVEAL). Chest. 2019 Feb 14 (epub)